TORONTO, ON / ACCESS Newswire / February 5, 2026 / Materials Inc. (TSX:NEXT) (OTCQB:NSRCF) ("NextSource" or the "Company") is pleased ...
Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results